Test Price
2,800 AED✅ Home Collection Available
KCNJ11 Gene Hyperinsulinemic Hypoglycemia Type 2 Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل KCNJ11 لفرط الأنسولينية الخلقي من النوع الثاني في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي
Clinically validated Next‑Generation Sequencing (NGS) for definitive diagnosis of congenital hyperinsulinism. Home collection included. License: 9834453.
Executive Summary
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: Hospital‑Grade Home Collection with ISO‑Certified Cold‑Chain transport and VIP Mobile Phlebotomy (8 AM – 11 PM).
- ✓ Clinical Guidance: Telephonic post‑test result interpretation by a DHA‑licensed specialist.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الملخص التنفيذي
- ✓ فحص جيني متطور لتسلسل الجين KCNJ11 باستخدام تقنية التسلسل من الجيل التالي (NGS)، يكشف عن الطفرات المسببة لفرط الأنسولينية الخلقي من النوع الثاني بدقة تشخيصية 99.9%.
- ✓ يشمل خدمة السحب المنزلي من قبل فريق تمريض معتمد، ونقل العينات تحت سلسلة تبريد معتمدة وفق معايير ISO.
- ✓ استشارة طبية هاتفية بعد النتائج لتفسيرها مع أخصائي مرخّص من هيئة الصحة بدبي.
- ✓ التحقق المباشر من التغطية التأمينية عبر واتساب +971 54 548 8731.
Overview
This test sequences the entire coding region of the KCNJ11 gene to identify pathogenic variants causing hyperinsulinemic hypoglycemia type 2 (congenital hyperinsulinism). With a turnaround of 3–4 weeks, our NGS‑based analysis delivers the highest diagnostic yield, enabling precise, individualized treatment for affected infants and adults.
| Feature | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Diagnostic Sensitivity | 99.9% (full gene coverage) | ~85% (targets known mutations only) |
| Methodology | Next‑Generation Sequencing (NGS) with bioinformatic variant interpretation | Sanger sequencing of selected exons |
| Turnaround Time | 3–4 weeks | 2–3 weeks (but may require reflex NGS) |
Physician Insight & Safety Protocol
“As a DHA‑licensed clinician, I emphasize that genetic results must be interpreted within the full clinical picture. KCNJ11 mutations can present with life‑threatening neonatal hypoglycaemia; thus, rapid molecular confirmation is critical. This test provides the clarity needed to guide therapy, but it does not replace continuous glucose monitoring and expert endocrine management.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ Medication Advisory: Do not discontinue or adjust any prescribed medication (e.g., diazoxide, octreotide) without explicit consultation with your treating physician. Test results do not constitute immediate management changes.
Safety Exclusion Criteria & Emergency Red Flags
- Neonates with persistent hypoglycaemia (glucose <2.5 mmol/L) must be under continuous medical supervision prior to collection.
- Do not postpone urgent clinical care for genetic results. If the patient develops seizures, lethargy, or poor feeding, seek emergency care immediately.
- Home collection is not permitted if the patient has a central line infection or unstable vital signs; hospital‑based sampling may be required.
- Individuals on systemic anticoagulation must inform the phlebotomist; a safety assessment will be conducted before venipuncture.
Frequently Asked Questions (FAQ)
What does the KCNJ11 NGS test detect, and why is it important?
This test identifies all pathogenic variants in the KCNJ11 gene that cause congenital hyperinsulinism, allowing precise diagnosis and guiding life‑saving therapy such as diazoxide or subtotal pancreatectomy. يكشف هذا الاختبار جميع الطفرات الممرضة في جين KCNJ11 المسببة لفرط الأنسولينية الخلقي، مما يتيح التشخيص الدقيق وتوجيه العلاج المناسب.
How should I prepare for the home blood collection?
No fasting is required; however, please share your clinical history and any anticoagulant use with our team before the visit. لا يشترط الصيام، لكن يجب إبلاغ الفريق الطبي بالتاريخ المرضي وأي استخدام لمضادات التخثر قبل سحب العينة.
How reliable are the results, and who interprets them?
With 99.9% diagnostic sensitivity and ISO‑accredited bioinformatics, results are clinically actionable; a DHA‑licensed genetic counsellor provides a telephonic interpretation session. بدقة تشخيصية 99.9% واعتماد ISO، تكون النتائج قابلة للاستخدام سريرياً، ويقوم مستشار وراثي مرخّص من هيئة الصحة بدبي بتفسيرها عبر الهاتف.
Pre‑ Requirement: A genetic counselling session with pedigree charting is mandatory. Contact our team to schedule.
For appointments & insurance verification: WhatsApp +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians